Clinical Trial Update: A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations [Phase 1]

View source ↗

Summary

ATV-1601, an investigational therapy, is being studied in a Phase 1 trial for patients with AKT1 E17K-mutant cancers, including breast, cervical, endometrial, o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• ATV-1601

Snippet

Sponsor: Atavistik Bio, Inc | Conditions: Advanced Solid Tumors, Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING